In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NantPharma LLC

Division of NantWorks LLC
nantpharma.com

Latest From NantPharma LLC

Celgene Settlement With Actavis Allows Abraxane Generics In 2022

Celgene settles Abraxane patent litigation and inter partes review with Teva's Actavis, allowing a generic to enter the market on March 31, 2022 – about four years before the drug's key patents expire.

Intellectual Property Legal Issues

Amgen's Cancer Strategy: A Multitude Of Modalities In Immuno-Oncology And Beyond

Amgen is the leader in approved bispecific antibodies and oncolytic viruses, but the company's not shy about expanding its oncology pipeline with even more modes of delivering medicines to cancer patients.

Cancer Clinical Trials

Biden’s Cancer Initiative May Intensify Industry, Government Collaboration

Drug companies and NIH embrace Vice President’s call for moonshot to cure cancer; Amgen and Celgene join separate coalition to test 60 molecules in combination Phase II studies.

BioPharmaceutical

Regen Medicine Drives Big Uptick In 2015 Start-Up Dealmaking

Biotech start-ups cut deals at a rapid pace in 2015, signing almost twice the number of alliances done in 2014. Regenerative medicine was prominent in key partnerships.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NantWorks LLC
  • Senior Management
  • Richard J Tajak, CFO
    Patrick Soon-Shiong, MD, Chmn.
    Ralph Yamamoto, VP, R&D
    Kevin J Forney, VP, Bus. Ops.
  • Contact Info
  • NantPharma LLC
    Phone: (847) 243-1200
    250 Parkway Dr., Ste. 380
    Lincolnshire, IL 60069
    USA
UsernamePublicRestriction

Register